CST: 26/06/2016 04:53:01   

Excellence in Pharmaceutical Pricing and Market Access Conference

148 Days ago

Successfully Navigating Policy Reform and Value-Based Contracting to Achieve Best-in-Class Pricing and Market Access

PHILADELPHIA, PA --(Marketwired - January 29, 2016) - This topical conference will bring together leaders in pricing and market access, healthcare outcomes, and managed markets to strategize about controversial pharmaceutical pricing. Attendees will receive practical knowledge and advice on how to negotiate value-based contracts and gain latest insights surrounding industry reforms and compliance updates.

marcus evans will host the Excellence in Pharmaceutical Pricing and Market Access Conference on April 5-7, 2016 in Philadelphia, PA. Through case study presentations and panel discussions the delegation will discuss legislative reforms, strategize about controversial pharmaceutical pricing, debate clinical trial requirements, and prepare to manage value-based contracts, returning home with better insight into the changing market and how to plan for the future.

Attending this premier conference will enable you to:

  • Anticipate litigation hurdles to efficiently assemble value-based contracts
  • Discover patient adherence solutions to bolster data integrity
  • Analyze looming policy changes to prepare for industry impact
  • Value specialty products to align cost and worth
  • Generate vigorous clinical evidence to maximize reimbursement opportunities

Past Attendees Include: Takeda Pharmaceuticals International Co., Baxter Healthcare Corporation, Inc., GlaxoSmithKline, AbbVie, Inc., Genentech, Inc., Boston Scientific, Allergan, Vertex Pharmaceuticals Incorporated, , Otsuka Pharmaceuticals, and many more!

Featuring Case Studies from Leading Pharma Practitioners, including:

Oved Amitay
Vice President, Head of Commercial
Alnylam Pharmaceuticals

Jay Greissing
Director, U.S. Government Relations and Public Policy
Shire Pharmaceuticals

Timothy J. Foster, Sr.
Senior Director, Client Engagement
OptumRx, a division of United Health Group

Christopher Jackson
Senior Director, Pricing Integrity
The Medicines Company

Mark Stephan
Senior National Managed Markets Director
Alkermes

Satish Valluri
Director of Global Market Access
Pfizer

Josh Tomas O'Harra
Associate General Counsel
Eli Lilly and Company

Testimonials:

"Good conference with a wide range of topics discussed. Very good speakers with very extensive knowledge & experience." Candence Pharmaceuticals

"Overall excellent selection of speakers. They were very knowledgeable & credible."Sanofi-Aventis

"Great peer to peer interaction with all participants. Well worth attending!" Medidata

For more information go to the conference website or email Rachel Strug, Digital Marketing Coordinator, at rachels@marcusevansch.com

marcus evans annually produces 2,000 high quality conferences designed to provide strategic business information and networking opportunities for industry leaders.

Rachel Strug
Digital Marketing Coordinator 
rachels@marcusevansch.com